{"title":"CD3/CD20/CD45 negative leukemia cutis.","authors":"Ilya Tsvetnov, Ihar Haiduk, Kirill A Lyapichev","doi":"10.1007/s12308-025-00620-2","DOIUrl":null,"url":null,"abstract":"<p><p>A 56-year-old male presented to the clinic with complaints of multiple skin lesions. A complete blood count (CBC) was not available. No constitutional symptoms were present, and physical examination revealed tender skin lesions of the back, arms, legs, and scalp. A skin punch biopsy showed fragments of skin with extensive lymphoid infiltrates. The initial lymphoma workup by immunohistochemistry demonstrated negative staining for CD45, CD3, and CD20. Additional stains were performed which revealed the atypical lymphoid infiltrate to be positive for PAX5, TdT, CD10, CD34, CD79a, and CD99 and negative for CD4, CD8, Keratin, S100, CD56, CD138, and EMA. These histologic and immunophenotypic findings supported the diagnosis of skin involvement by B-lymphoblastic leukemia/lymphoma (B-ALL/LBL). Consequent peripheral blood and bone marrow biopsy evaluations supported this diagnosis. To avoid misdiagnosis, it is important to remember that B-ALL/LBL can rarely present as a skin lesion and can be negative for the most commonly used lymphoma immunohistochemical markers: CD45, CD3, and CD20. Additionally, skin involvement by B-ALL/LBL, although very uncommon, is most often reported in children or young adults, unlike this unique case occurring in an adult.</p>","PeriodicalId":51320,"journal":{"name":"Journal of Hematopathology","volume":"18 1","pages":"4"},"PeriodicalIF":0.6000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hematopathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12308-025-00620-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
一名 56 岁的男性因多处皮肤损伤前来就诊。未做全血细胞计数(CBC)。体格检查显示背部、手臂、腿部和头皮有触痛性皮损。皮肤打孔活检显示皮肤碎片上有大量淋巴细胞浸润。通过免疫组化对淋巴瘤进行初步检查,结果显示 CD45、CD3 和 CD20 染色阴性。进行了其他染色后发现,非典型淋巴浸润的 PAX5、TdT、CD10、CD34、CD79a 和 CD99 呈阳性,CD4、CD8、角蛋白、S100、CD56、CD138 和 EMA 呈阴性。这些组织学和免疫分型结果支持 B 淋巴细胞白血病/淋巴瘤(B-ALL/LBL)累及皮肤的诊断。随后的外周血和骨髓活检评估也支持这一诊断。为避免误诊,重要的是要记住 B-ALL/LBL 很少表现为皮肤病变,最常用的淋巴瘤免疫组化标记物也可能是阴性的:CD45、CD3 和 CD20。此外,B-ALL/LBL累及皮肤的病例虽然非常少见,但多见于儿童或青壮年,这与本例独特的成人病例不同。
A 56-year-old male presented to the clinic with complaints of multiple skin lesions. A complete blood count (CBC) was not available. No constitutional symptoms were present, and physical examination revealed tender skin lesions of the back, arms, legs, and scalp. A skin punch biopsy showed fragments of skin with extensive lymphoid infiltrates. The initial lymphoma workup by immunohistochemistry demonstrated negative staining for CD45, CD3, and CD20. Additional stains were performed which revealed the atypical lymphoid infiltrate to be positive for PAX5, TdT, CD10, CD34, CD79a, and CD99 and negative for CD4, CD8, Keratin, S100, CD56, CD138, and EMA. These histologic and immunophenotypic findings supported the diagnosis of skin involvement by B-lymphoblastic leukemia/lymphoma (B-ALL/LBL). Consequent peripheral blood and bone marrow biopsy evaluations supported this diagnosis. To avoid misdiagnosis, it is important to remember that B-ALL/LBL can rarely present as a skin lesion and can be negative for the most commonly used lymphoma immunohistochemical markers: CD45, CD3, and CD20. Additionally, skin involvement by B-ALL/LBL, although very uncommon, is most often reported in children or young adults, unlike this unique case occurring in an adult.
期刊介绍:
The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with all the information needed to perform modern pathology in evaluating lymphoid tissues and bone marrow. To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, and occasional case reports in the fields of the pathology, molecular biology, and clinical features of diseases of the hematopoietic system.
The journal is the unique reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other diseases.
The journal is unique in its true international character. Especially in the field of hematopathology it is clear that there are huge geographical variations in incidence of diseases. This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients.